NASDAQ · Medical Care Facilities · USD
LifeStance Health Group, Inc. (LFST) Stock Analysis
LifeStance Health Group, Inc. (LFST) is a Medical Care Facilities stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
LFST Key Statistics
As of Oct 21, 2026Trading
- Open
- $12.13
- Previous Close
- $12.22
- Day's Range
- 12.01–12.40
- 52-Week Range
- 4.77–13.56
- Volume
- 3.55M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 1.24
Valuation
- Market Cap
- $4.69B
- P/E Ratio
- 94.85
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 28.62
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 2.96
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 0.13
Financials (FY)
- Revenue (FY)
- $1.42B+13.85%
- Net Income (FY)
- $9.66M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 3.19%
- Shares Outstanding
- 380.15M
- 1-Year Return
- +137.12%
Dividend and dates
- Earnings Date
- November 5, 2026
- Avg Volume
- 4.26M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, LFST closed at $12.33, +137.12% over 1 year.
LifeStance Health Group, Inc. (LFST) has a market capitalization of $4.69B.
In fiscal 2025, LFST reported revenue of $1.42B.
LFST Stock Return by Calendar Year
LifeStance Health Group, Inc. (LFST) return since Jun 2021: what $10,000 became
- 1 year
- $10,000 $23,712
- +137.12%
- 5 years
- $10,000 $10,547
- +5.47%
- Since Jun 2021
- $10,000 $5,630
- −43.70%
If you had invested $10,000 in LifeStance Health Group, Inc. (LFST) at the close on June 10, 2021, the earliest close on record here, it would have been worth $5,630 at the close on October 21, 2026: −43.70% in total, −10.16% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +75.14% |
| 2025 | −4.48% |
| 2024 | −5.87% |
| 2023 | +58.50% |
| 2022 | −48.11% |
| 2021 (partial year) | −56.53% |
As of October 21, 2026.
LFST Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $1.42B | $9.66M | 0.7% |
| 2024 | $1.25B | −$57.44M | −4.6% |
| 2023 | $1.06B | −$186.26M | −17.6% |
| 2022 | $859.54M | −$215.56M | −25.1% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $1.42B | $461.10M | $24.15M | $9.66M | 0.7% |
| 2024 | $1.25B | $402.40M | −$31.61M | −$57.44M | −4.6% |
| 2023 | $1.06B | $302.10M | −$189.13M | −$186.26M | −17.6% |
| 2022 | $859.54M | $237.02M | −$210.17M | −$215.56M | −25.1% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
LFST Valuation vs Medical Care Facilities Median
Median of 54 stocks| Metric | LFST | Medical Care Facilities median | vs median |
|---|---|---|---|
| P/E | 94.85 | 20.67 | 4.6x the median |
| P/S ratio | 2.96 | 0.87 | 3.4x the median |
| Profit margin | 3.19% | 3.19% | 0.0 pts above |
Medians across 54 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026
YahooTranscript: LifeStance Health Gr Q2 2026 Earnings Conference Call
BenzingaKeybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15
BenzingaNearly Half of Americans Say Fear of an Unwanted Viral Moment Keeps Them from Being Themselves in Public, LifeStance Survey Finds
YahooWhat’s Going On With LifeStance Health Group (LFST)?
YahooLifeStance Health CTO Sells 42,067 Shares for $541,402
The Motley Fool
All 20 articles ↓Show fewer ↑
LifeStance Health Group (LFST): Buy, Sell, or Hold Post Q2 Earnings?
YahooLifeStance Health Group (NASDAQ:LFST): Strongest Q2 Results from the Outpatient & Specialty Care Group
YahooLifeStance Health Group, Inc. (LFST) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
SeekingAlphaLifeStance Health Group (NASDAQ:LFST) Passes Minervini Trend Template and High Growth Momentum Screen
ChartMillZacks.com featured highlights include LifeStance Health, Tutor Perini, News, Everus Construction and HF Sinclair
YahooHere's Why LifeStance Health Group (LFST) is a Great Momentum Stock to Buy
YahooBarclays Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15
BenzingaCanaccord Genuity Maintains Buy on LifeStance Health Gr, Raises Price Target to $15
BenzingaLifeStance Health Group Announces Pricing of Secondary Public Offering
YahooLifeStance Health Group Announces Launch of Secondary Public Offering
YahooLifeStance Prices 22.25M Share Secondary Offering At $12.35/Share; Co To Repurchase 2M Shares
BenzingaLifeStance Health Group (LFST) Has Rallied Sharply, Is The Stock Still Undervalued?
YahooLifeStance Health Group (LFST) Stock May Be Above Fair Value On Its 137% Run
YahooLifeStance Health Group, Inc. (LFST) Hit a 52 Week High, Can the Run Continue?
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Medical Care Facilities Stocks
HCA Healthcare, Inc.
$99.46B
THCTenet Healthcare Corporation
$21.67B
EHCEncompass Health Corporation
$11.88B
FMSFresenius Medical Care AG
$11.47B
DVADaVita Inc.
$11.28B
UHSUniversal Health Services, Inc.
$10.78B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B












